Boothbay Fund Management’s VIVEVE MED INC VIVE Stock Holding History

Boothbay Fund Management’s Portfolio VIVE Stock Details VIVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,446	Closed	-$69K	–	1146
2019 Q4	$69K	Buy	+5,446	New	+$155K	0.01%	787
2019 Q3	–	Sell	-32	Closed	-$12K	–	952
2019 Q2	$12K	Hold	32	–	–	﹤0.01%	706
2019 Q1	$30K	Sell	32 -2	-6%	-$2.12K	﹤0.01%	718
2018 Q4	$35K	Buy	+34	New	+$81.6K	0.01%	601

Other funds holding VIVE

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JCM

Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Boothbay Fund Management's VIVE Position: Q1 2020 in Review

Boothbay Fund Management sold out of VIVEVE MED INC (VIVE) in Q1 2020, closing a stake of 5,446 shares — an estimated $69K sold.

Boothbay Fund Management first reported a position in VIVE in Q4 2018 and held it in 4 quarters. The position peaked at $69K in Q4 2019. 11 funds tracked by Wall St. Rank hold VIVE as of Q1 2020.

Boothbay Fund Management reported no remaining VIVEVE MED INC position as of Q1 2020 after selling out during the quarter.
Boothbay Fund Management sold 5,446 VIVEVE MED INC shares in Q1 2020, an estimated $69K.
Boothbay Fund Management first reported a position in VIVEVE MED INC in Q4 2018 and held it in 4 quarters.
Boothbay Fund Management's VIVEVE MED INC position peaked at $69K in Q4 2019.
11 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.